Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
ER.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
ER.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ER.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
ER.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
ER.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
ER.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
ER.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ER.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CQ.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CQ.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CQ.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CQ.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3406.8South Korea
BA.5.2.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2824.15Germany
BA.5.2.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.129 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.129 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.129 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.129 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.129 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.129 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.129 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.129 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAY.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.2.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XAY.2.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAY.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used